Colorectal Cancer Treatment Market Size, Trends, Growth & Forecast 2025-2031
Colorectal Cancer Treatment Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment (Surgery, Chemotherapy, Immunotherapy, Targeted Therapy, and Others), Age Group (Below 49 Years, 50 - 64 Years and Above 65 Years), End Users (Hospitals, Specialty Clinics, Home Care, and Others), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, South and Central America)
- Report Date : Aug 2025
- Report Code : TIPRE00038988
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 241
The colorectal cancer treatment market size is projected to reach US$ 24.74 billion by 2031 from US$ 19.93 billion in 2024. The market is expected to register a CAGR of 3.2% during 2025–2031.
Colorectal Cancer Treatment Market Analysis
The growing number of colorectal cancer cases and increasing advancements in targeted and immunotherapies are propelling the use of colorectal cancer treatments. Colorectal cancer treatment involves a combination of therapies based on the cancer's stage and location. Early-stage disease is typically treated with surgery to remove tumors. In more advanced stages, treatment may include chemotherapy, radiation therapy, and targeted or immunotherapy for tumors with specific genetic markers. For metastatic cases, systemic therapies help control disease spread. Personalized treatment plans are developed using molecular profiling. Supportive care addresses symptoms, nutrition, and quality of life.
The regulatory acceleration and support for novel treatments present a significant opportunity for the colorectal cancer treatment market, fueling the market growth.
Colorectal Cancer Treatment Market Overview
North America is projected to dominate the colorectal cancer treatment market with the largest share, and Asia Pacific is expected to register a significant CAGR during the forecast period. The colorectal cancer treatment market in Asia Pacific is growing rapidly. This region includes major countries such as China, Japan, India, South Korea, Australia, and the broader Asia Pacific area, each contributing to this market expansion. North America, particularly the US, records a high prevalence of colorectal cancer. Also, a large elderly population is at a greater risk of the disease. The rising number of colorectal cancer cases fuels the demand for advanced therapeutics and treatment options.
The rising number of colorectal cancer cases fuels the demand for advanced therapeutics and treatment options. Technological advancements and access to cost-effective manufacturing in the region allow companies to produce efficient drugs at competitive prices, further enhancing their market presence.
Government bodies are making colorectal cancer treatments accessible by implementing people-friendly reimbursement policies and other healthcare initiatives to provide satisfactory cost coverage for colorectal cancer therapeutics.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Colorectal Cancer Treatment Market: Strategic Insights
Market Size Value in US$ 18.810 billion in 2022 Market Size Value by US$ 23.978 billion by 2030 Growth rate CAGR of 3.1% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Colorectal Cancer Treatment Market Drivers and Opportunities
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Colorectal Cancer Treatment Market: Strategic Insights
| Market Size Value in | US$ 18.810 billion in 2022 |
| Market Size Value by | US$ 23.978 billion by 2030 |
| Growth rate | CAGR of 3.1% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Drivers:
Growing Number of Colorectal Cancer Cases:
The increasing number of colorectal cancer cases is driven by a convergence of demographic trends, lifestyle changes, and shifting patterns in early-onset disease, which are reflected in recent epidemiological statistics and scientific developments.Increasing Advancements in Targeted and Immunotherapies:
A central driver of progress in the colorectal cancer treatment market has been remarkable advancements in targeted immunotherapies, fundamentally reshaping outcomes for specific patient populations and expanding future therapeutic possibilities.Surging Developments in Precision Medicine:
Many novel colorectal cancer treatments, especially biologics and cell therapies, carry high price tags. This increases affordability concerns, strains public health budgets, and creates access disparities. Payers and governments increasingly assess value-based pricing, leading to debates on pricing transparency, reimbursement models, and global cost-containment policies.
Market Opportunities:
Regulatory Acceleration and Support for Novel Treatments:
The colorectal cancer treatment landscape is witnessing a profound opportunity driven by proactive regulatory acceleration and support for novel therapies, reshaping access, innovation, and patient outcomes.
Expansion in Emerging Economies:
Several countries in Asia Pacific, Latin America, and Africa offer growth opportunities in the colorectal cancer treatment market due to the increasing number of colorectal cancer cases and awareness.Rising Medical Tourism:
Increasing medical tourism in developing countries such as China, India, Indonesia, Brazil, and Mexico offers affordable advanced care and treatments, 30–80% less than in the US and European countries.Increased Support from Government and Private Organizations:
Several governments and private organizations have increased funding for research and development in colorectal cancer treatment, resulting in the development of innovative drugs and therapies.
Technological Advancements
Technological advancements and access to cost-effective manufacturing in the region allow companies to produce innovative drugs at competitive prices, further enhancing their market presence.
Colorectal Cancer Treatment Market Report Segmentation Analysis
The colorectal cancer treatment market is divided into segments to give a clearer view of how it works, its growth potential, and the latest trends. Below is the standard segmentation approach used in most industry reports:
By Treatment:
Surgery:
Surgery remains the cornerstone treatment for localized and advanced colorectal cancer, with innovations such as robotic-assisted and laparoscopic surgeries improving outcomes and reducing recovery times.Chemotherapy:
The chemotherapy segment holds a significant share in the global colorectal cancer treatment market, driven by its longstanding role as a frontline systemic therapy for managing both early-stage and advanced colorectal malignancies.
Targeted Therapy:
Targeted drugs inhibit cancer cells' growth by destroying or slowing down their growth. Targeted therapy is used in combination with traditional chemotherapy.Immunotherapy:
Immunotherapy leverages an individual's immune system to recognize and destroy cancer cells effectively. It typically targets specific proteins in the body's immune system to enhance the immune response.Other Therapy Types:
Gene therapy, radiation therapy, and epigenetic therapy are a few of the most innovative and promising approaches in colorectal cancer treatment.
By Age Group:
Below 49 Years:
CRC was traditionally considered a disease of older adults, but recent data show a concerning increase in younger populations. Treatment approaches for younger CRC patients are evolving, focusing on minimizing long-term side effects and improving quality of life.50–64 Years:
Colorectal cancer is increasingly affecting younger populations, with individuals aged 50–64 now representing a significant proportion of new cases. Colorectal cancer is increasingly affecting younger populations, with individuals aged 50–64 now representing a significant proportion of new cases.Above 65 Years:
As global populations age, the proportion of individuals aged 65 and above is rising significantly. According to the WHO, by 2030, 1 in 6 people worldwide will be aged 60 or older, with the 80+ age group growing the fastest. Since age is the single most significant risk factor for colorectal cancer—with ~75% of cases diagnosed in individuals over 65—this demographic shift directly expands the patient pool requiring treatment.
By End Users:
- Hospitals
- Specialty Clinics
- Home Care
- Others
By Geography:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
The colorectal cancer treatment market in North America is expected to hold a significant market share. Increasing colorectal cancer prevalence and business expansion strategies by the market players are likely to drive the market.
Colorectal Cancer Treatment Market Report ScopeColorectal Cancer Treatment Market Share Analysis by Geography
Asia Pacific is expected to grow the fastest in the next few years. Emerging markets in Latin America, the Middle East, and Africa also have many untapped opportunities for colorectal cancer treatment providers to expand.
The colorectal cancer treatment market grows differently in each region. This is because of factors like the growing number of colorectal cancer cases, increasing advancements in targeted and immunotherapies, and increasing adoption of innovative oncology drugs. Below is a summary of market share and trends by region:
1. North America
Market Share:
Holds a significant portion of the global marketKey Drivers:
- Growing number of colorectal cancer cases
- Increasing advancements in targeted and immunotherapies
- Surging development in personalized medicine
Trends:
Adoption of organic and inorganic strategies by colorectal cancer treatment manufacturers.
2. Europe
Market Share:
Substantial share due to early adoption of digital commerceKey Drivers:
- Rising prevalence of colorectal cancer
- Strict government regulation for colorectal cancer treatment
Trends:
Technological advancements in colorectal cancer treatment
3. Asia Pacific
Market Share:
Fastest-growing region with a rising market share every yearKey Drivers:
- Rapid improvements in healthcare infrastructure, supported by increasing government investments in public health.
- Growing awareness of colorectal cancer treatment among the public and various institutions.
Trends:
Rise in medical tourism
4. South and Central America
Market Share:
Growing market with steady progressKey Drivers:
- Growing number of cancer cases
- Increasing import of pharmaceutical drugs
Trends:
Rise in medical tourism
5. Middle East and Africa
Market Share:
Although small, but growing quicklyKey Drivers:
- Expanding healthcare infrastructure
- Rising awareness about colorectal cancer treatment in healthcare settings
Trends:
Government initiatives for colorectal cancer treatment awareness
Colorectal Cancer Treatment Market Players Density: Understanding Its Impact on Business Dynamics
High Market Density and Competition
Competition is strong due to established players such as Roche, Pfizer, Sanofi, Merck, Bristol-Myers Squibb, Amgen, and Lilly. Regional and niche providers such as Novugen Pharma (Malaysia) and Kalbe Farma (Asia Pacific) also add to the competitive landscape across different regions.
This high level of competition urges companies to stand out by offering:
- Advanced Products
- Value-added Services such as Customization and Sustainable Solutions
- Competitive Pricing Models
- Compliance with Regulatory Guidelines
Opportunities and Strategic Moves
- Focusing on more effective and targeted cancer therapies. A surge in research and development investments is due to increasing cancer rates and the need for advanced therapies.
- Companies are moving towards next-generation oncology therapeutics and precision approaches to address regulatory and consumer concerns about cancer therapies
- Focusing on direct-to-consumer channels and enhancing the use of e-commerce platforms to reach a wider range of customer segments.
Major Companies operating in the Colorectal Cancer Treatment Market are:
- Bayer AG
- Bristol-Myers Squibb Co.
- Amgen Inc.
- Eli Lilly and Co.
- Genentech Inc. (F. Hoffmann-La Roche Ltd)
- Pfizer Inc.
- Takeda Pharmaceutical Co Ltd
- Teva Pharmaceutical Industries Ltd
- Regeneron Pharmaceuticals Inc.
- Otsuka Holdings Co., Ltd
Disclaimer: The companies listed above are not ranked in any particular order.
Other companies analysed during the course of research:
- Incyte
- Gilead Science, Inc.
- Daiichi Sankyo Co. Ltd
- Lupin Pharmaceuticals
- Ipsen
- Boehringer Ingelheim
- Glenmark Pharmaceuticals
- Gilead Sciences
- Odon Lifescience
- Cytogen Pharmaceuticals India Private Limited
- Bluebird Bio
- Biocon Limited
- BeiGene
- Ascendis Pharma
- Sun Pharmaceutical Industries
- Clovis Oncology
- Cipla Limited
- Blueprint Medicines
Colorectal Cancer Treatment Market News and Recent Developments
- Glenmark to Launch DCGI-Approved Cancer Drug in India
- Takeda Receives US FDA Approval of FRUZAQLA (fruquintinib) for Previously Treated Metastatic Colorectal Cancer.
- Guardant Health's Shield Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening
Colorectal Cancer Treatment Market Report Coverage and Deliverables
The "Colorectal Cancer Treatment Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
- Colorectal cancer treatment market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Colorectal cancer treatment market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Colorectal cancer treatment market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the colorectal cancer treatment market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Treatment Type, Age Group, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
North America dominated the market in 2024.
The growing number of colorectal cancer cases and increasing advancements in targeted and immunotherapies are among the noteworthy factors contributing to the market growth.
The colorectal cancer treatment market is estimated to register a CAGR of 3.2% during the forecast period.
Bristol-Myers Squibb Co., Bayer AG, Amgen Inc., Eli Lilly and Co., Genentech Inc. (F. Hoffmann-La Roche Ltd), Pfizer Inc., Takeda Pharmaceutical Co Ltd, Teva Pharmaceutical Industries Ltd, Regeneron Pharmaceuticals Inc., and Otsuka Holdings Co., Ltd. are among the key players operating in the colorectal cancer treatment market.
The colorectal cancer treatment market is estimated to reach US$ 24.74 billion by 2031.
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Analyst Market Outlook
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
3.3 Assumptions and Limitations
4. Colorectal Cancer Treatment Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Colorectal Cancer Treatment Market – Key Market Dynamics
5.1 Colorectal Cancer Treatment Market – Key Market Dynamics
5.2 Key Market Drivers
5.2.1 Growing Number of Colorectal Cancer Cases
5.2.2 Increasing Advancements in Targeted and Immunotherapies
5.3 Key Market Restraints
5.3.1 High Costs of Colorectal Cancer Treatments
5.4 Key Market Opportunities
5.4.1 Regulatory Acceleration and Support for Novel Treatments
5.5 Key Future Trends
5.5.1 Development of Novel Drug Delivery Methods
5.6 Impact of Drivers and Restraints:
6. Colorectal Cancer Treatment Market – Global Market Analysis
6.1 Colorectal Cancer Treatment Market Revenue (US$ Million), 2021–2031
6.2 Colorectal Cancer Treatment Market Forecast Analysis
7. Colorectal Cancer Treatment Market Analysis – by Treatment
7.1 Surgery
7.1.1 Overview
7.1.2 Surgery: Colorectal Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Chemotherapy
7.2.1 Overview
7.2.2 Chemotherapy: Colorectal Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Immunotherapy
7.3.1 Overview
7.3.2 Immunotherapy: Colorectal Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Targeted Therapy
7.4.1 Overview
7.4.2 Targeted Therapy: Colorectal Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Colorectal Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
8. Colorectal Cancer Treatment Market Analysis – by Age Group
8.1 Below 49 Years
8.1.1 Overview
8.1.2 Below 49 Years: Colorectal Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
8.2 - 64 Years
8.2.1 Overview
8.2.2 - 64 Years: Colorectal Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Above 65 Years
8.3.1 Overview
8.3.2 Above 65 Years: Colorectal Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
9. Colorectal Cancer Treatment Market Analysis – by End Users
9.1 Hospitals
9.1.1 Overview
9.1.2 Hospitals: Colorectal Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Specialty Clinics
9.2.1 Overview
9.2.2 Specialty Clinics: Colorectal Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Home Care
9.3.1 Overview
9.3.2 Home Care: Colorectal Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Others
9.4.1 Overview
9.4.2 Others: Colorectal Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
10. Colorectal Cancer Treatment Market – Geographical Analysis
10.1 Overview
10.2 North America
10.2.1 North America Colorectal Cancer Treatment Market Overview
10.2.2 North America: Colorectal Cancer Treatment Market – Revenue, 2021–2031 (US$ Million)
10.2.3 North America: Colorectal Cancer Treatment Market Breakdown, by Treatment
10.2.3.1 North America: Colorectal Cancer Treatment Market – Revenue and Forecast Analysis – by Treatment
10.2.4 North America: Colorectal Cancer Treatment Market Breakdown, by Age Group
10.2.4.1 North America: Colorectal Cancer Treatment Market – Revenue and Forecast Analysis – by Age Group
10.2.5 North America: Colorectal Cancer Treatment Market Breakdown, by End Users
10.2.5.1 North America: Colorectal Cancer Treatment Market – Revenue and Forecast Analysis – by End Users
10.2.6 North America: Colorectal Cancer Treatment Market – Revenue and Forecast Analysis – by Country
10.2.6.1 North America: Colorectal Cancer Treatment Market – Revenue and Forecast Analysis – by Country
10.2.6.2 United States: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.2.6.2.1 United States: Colorectal Cancer Treatment Market Breakdown, by Treatment
10.2.6.2.2 United States: Colorectal Cancer Treatment Market Breakdown, by Age Group
10.2.6.2.3 United States: Colorectal Cancer Treatment Market Breakdown, by End Users
10.2.6.3 Canada: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.2.6.3.1 Canada: Colorectal Cancer Treatment Market Breakdown, by Treatment
10.2.6.3.2 Canada: Colorectal Cancer Treatment Market Breakdown, by Age Group
10.2.6.3.3 Canada: Colorectal Cancer Treatment Market Breakdown, by End Users
10.2.6.4 Mexico: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.2.6.4.1 Mexico: Colorectal Cancer Treatment Market Breakdown, by Treatment
10.2.6.4.2 Mexico: Colorectal Cancer Treatment Market Breakdown, by Age Group
10.2.6.4.3 Mexico: Colorectal Cancer Treatment Market Breakdown, by End Users
10.3 Europe
10.3.1 Europe Colorectal Cancer Treatment Market Overview
10.3.2 Europe: Colorectal Cancer Treatment Market – Revenue, 2021–2031 (US$ Million)
10.3.3 Europe: Colorectal Cancer Treatment Market Breakdown, by Treatment
10.3.3.1 Europe: Colorectal Cancer Treatment Market – Revenue and Forecast Analysis – by Treatment
10.3.4 Europe: Colorectal Cancer Treatment Market Breakdown, by Age Group
10.3.4.1 Europe: Colorectal Cancer Treatment Market – Revenue and Forecast Analysis – by Age Group
10.3.5 Europe: Colorectal Cancer Treatment Market Breakdown, by End Users
10.3.5.1 Europe: Colorectal Cancer Treatment Market – Revenue and Forecast Analysis – by End Users
10.3.6 Europe: Colorectal Cancer Treatment Market – Revenue and Forecast Analysis – by Country
10.3.6.1 Europe: Colorectal Cancer Treatment Market – Revenue and Forecast Analysis – by Country
10.3.6.2 Germany: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.3.6.2.1 Germany: Colorectal Cancer Treatment Market Breakdown, by Treatment
10.3.6.2.2 Germany: Colorectal Cancer Treatment Market Breakdown, by Age Group
10.3.6.2.3 Germany: Colorectal Cancer Treatment Market Breakdown, by End Users
10.3.6.3 France: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.3.6.3.1 France: Colorectal Cancer Treatment Market Breakdown, by Treatment
10.3.6.3.2 France: Colorectal Cancer Treatment Market Breakdown, by Age Group
10.3.6.3.3 France: Colorectal Cancer Treatment Market Breakdown, by End Users
10.3.6.4 United Kingdom: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.3.6.4.1 United Kingdom: Colorectal Cancer Treatment Market Breakdown, by Treatment
10.3.6.4.2 United Kingdom: Colorectal Cancer Treatment Market Breakdown, by Age Group
10.3.6.4.3 United Kingdom: Colorectal Cancer Treatment Market Breakdown, by End Users
10.3.6.5 Italy: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.3.6.5.1 Italy: Colorectal Cancer Treatment Market Breakdown, by Treatment
10.3.6.5.2 Italy: Colorectal Cancer Treatment Market Breakdown, by Age Group
10.3.6.5.3 Italy: Colorectal Cancer Treatment Market Breakdown, by End Users
10.3.6.6 Spain: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.3.6.6.1 Spain: Colorectal Cancer Treatment Market Breakdown, by Treatment
10.3.6.6.2 Spain: Colorectal Cancer Treatment Market Breakdown, by Age Group
10.3.6.6.3 Spain: Colorectal Cancer Treatment Market Breakdown, by End Users
10.3.6.7 Rest of Europe: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.3.6.7.1 Rest of Europe: Colorectal Cancer Treatment Market Breakdown, by Treatment
10.3.6.7.2 Rest of Europe: Colorectal Cancer Treatment Market Breakdown, by Age Group
10.3.6.7.3 Rest of Europe: Colorectal Cancer Treatment Market Breakdown, by End Users
10.4 Asia Pacific
10.4.1 Asia Pacific Colorectal Cancer Treatment Market Overview
10.4.2 Asia Pacific: Colorectal Cancer Treatment Market – Revenue, 2021–2031 (US$ Million)
10.4.3 Asia Pacific: Colorectal Cancer Treatment Market Breakdown, by Treatment
10.4.3.1 Asia Pacific: Colorectal Cancer Treatment Market – Revenue and Forecast Analysis – by Treatment
10.4.4 Asia Pacific: Colorectal Cancer Treatment Market Breakdown, by Age Group
10.4.4.1 Asia Pacific: Colorectal Cancer Treatment Market – Revenue and Forecast Analysis – by Age Group
10.4.5 Asia Pacific: Colorectal Cancer Treatment Market Breakdown, by End Users
10.4.5.1 Asia Pacific: Colorectal Cancer Treatment Market – Revenue and Forecast Analysis – by End Users
10.4.6 Asia Pacific: Colorectal Cancer Treatment Market – Revenue and Forecast Analysis – by Country
10.4.6.1 Asia Pacific: Colorectal Cancer Treatment Market – Revenue and Forecast Analysis – by Country
10.4.6.2 China: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.4.6.2.1 China: Colorectal Cancer Treatment Market Breakdown, by Treatment
10.4.6.2.2 China: Colorectal Cancer Treatment Market Breakdown, by Age Group
10.4.6.2.3 China: Colorectal Cancer Treatment Market Breakdown, by End Users
10.4.6.3 Japan: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.4.6.3.1 Japan: Colorectal Cancer Treatment Market Breakdown, by Treatment
10.4.6.3.2 Japan: Colorectal Cancer Treatment Market Breakdown, by Age Group
10.4.6.3.3 Japan: Colorectal Cancer Treatment Market Breakdown, by End Users
10.4.6.4 India: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.4.6.4.1 India: Colorectal Cancer Treatment Market Breakdown, by Treatment
10.4.6.4.2 India: Colorectal Cancer Treatment Market Breakdown, by Age Group
10.4.6.4.3 India: Colorectal Cancer Treatment Market Breakdown, by End Users
10.4.6.5 South Korea: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.4.6.5.1 South Korea: Colorectal Cancer Treatment Market Breakdown, by Treatment
10.4.6.5.2 South Korea: Colorectal Cancer Treatment Market Breakdown, by Age Group
10.4.6.5.3 South Korea: Colorectal Cancer Treatment Market Breakdown, by End Users
10.4.6.6 Australia: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.4.6.6.1 Australia: Colorectal Cancer Treatment Market Breakdown, by Treatment
10.4.6.6.2 Australia: Colorectal Cancer Treatment Market Breakdown, by Age Group
10.4.6.6.3 Australia: Colorectal Cancer Treatment Market Breakdown, by End Users
10.4.6.7 Rest of APAC: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.4.6.7.1 Rest of APAC: Colorectal Cancer Treatment Market Breakdown, by Treatment
10.4.6.7.2 Rest of APAC: Colorectal Cancer Treatment Market Breakdown, by Age Group
10.4.6.7.3 Rest of APAC: Colorectal Cancer Treatment Market Breakdown, by End Users
10.5 Middle East and Africa
10.5.1 Middle East and Africa Colorectal Cancer Treatment Market Overview
10.5.2 Middle East and Africa: Colorectal Cancer Treatment Market – Revenue, 2021–2031 (US$ Million)
10.5.3 Middle East and Africa: Colorectal Cancer Treatment Market Breakdown, by Treatment
10.5.3.1 Middle East and Africa: Colorectal Cancer Treatment Market – Revenue and Forecast Analysis – by Treatment
10.5.4 Middle East and Africa: Colorectal Cancer Treatment Market Breakdown, by Age Group
10.5.4.1 Middle East and Africa: Colorectal Cancer Treatment Market – Revenue and Forecast Analysis – by Age Group
10.5.5 Middle East and Africa: Colorectal Cancer Treatment Market Breakdown, by End Users
10.5.5.1 Middle East and Africa: Colorectal Cancer Treatment Market – Revenue and Forecast Analysis – by End Users
10.5.6 Middle East and Africa: Colorectal Cancer Treatment Market – Revenue and Forecast Analysis – by Country
10.5.6.1 Middle East and Africa: Colorectal Cancer Treatment Market – Revenue and Forecast Analysis – by Country
10.5.6.2 Saudi Arabia: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.5.6.2.1 Saudi Arabia: Colorectal Cancer Treatment Market Breakdown, by Treatment
10.5.6.2.2 Saudi Arabia: Colorectal Cancer Treatment Market Breakdown, by Age Group
10.5.6.2.3 Saudi Arabia: Colorectal Cancer Treatment Market Breakdown, by End Users
10.5.6.3 South Africa: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.5.6.3.1 South Africa: Colorectal Cancer Treatment Market Breakdown, by Treatment
10.5.6.3.2 South Africa: Colorectal Cancer Treatment Market Breakdown, by Age Group
10.5.6.3.3 South Africa: Colorectal Cancer Treatment Market Breakdown, by End Users
10.5.6.4 United Arab Emirates: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.5.6.4.1 United Arab Emirates: Colorectal Cancer Treatment Market Breakdown, by Treatment
10.5.6.4.2 United Arab Emirates: Colorectal Cancer Treatment Market Breakdown, by Age Group
10.5.6.4.3 United Arab Emirates: Colorectal Cancer Treatment Market Breakdown, by End Users
10.5.6.5 Rest of Middle East and Africa: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.5.6.5.1 Rest of Middle East and Africa: Colorectal Cancer Treatment Market Breakdown, by Treatment
10.5.6.5.2 Rest of Middle East and Africa: Colorectal Cancer Treatment Market Breakdown, by Age Group
10.5.6.5.3 Rest of Middle East and Africa: Colorectal Cancer Treatment Market Breakdown, by End Users
10.6 South and Central America
10.6.1 South and Central America Colorectal Cancer Treatment Market Overview
10.6.2 South and Central America: Colorectal Cancer Treatment Market – Revenue, 2021–2031 (US$ Million)
10.6.3 South and Central America: Colorectal Cancer Treatment Market Breakdown, by Treatment
10.6.3.1 South and Central America: Colorectal Cancer Treatment Market – Revenue and Forecast Analysis – by Treatment
10.6.4 South and Central America: Colorectal Cancer Treatment Market Breakdown, by Age Group
10.6.4.1 South and Central America: Colorectal Cancer Treatment Market – Revenue and Forecast Analysis – by Age Group
10.6.5 South and Central America: Colorectal Cancer Treatment Market Breakdown, by End Users
10.6.5.1 South and Central America: Colorectal Cancer Treatment Market – Revenue and Forecast Analysis – by End Users
10.6.6 South and Central America: Colorectal Cancer Treatment Market – Revenue and Forecast Analysis – by Country
10.6.6.1 South and Central America: Colorectal Cancer Treatment Market – Revenue and Forecast Analysis – by Country
10.6.6.2 Brazil: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.6.6.2.1 Brazil: Colorectal Cancer Treatment Market Breakdown, by Treatment
10.6.6.2.2 Brazil: Colorectal Cancer Treatment Market Breakdown, by Age Group
10.6.6.2.3 Brazil: Colorectal Cancer Treatment Market Breakdown, by End Users
10.6.6.3 Argentina: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.6.6.3.1 Argentina: Colorectal Cancer Treatment Market Breakdown, by Treatment
10.6.6.3.2 Argentina: Colorectal Cancer Treatment Market Breakdown, by Age Group
10.6.6.3.3 Argentina: Colorectal Cancer Treatment Market Breakdown, by End Users
10.6.6.4 Rest of South and Central America: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.6.6.4.1 Rest of South and Central America: Colorectal Cancer Treatment Market Breakdown, by Treatment
10.6.6.4.2 Rest of South and Central America: Colorectal Cancer Treatment Market Breakdown, by Age Group
10.6.6.4.3 Rest of South and Central America: Colorectal Cancer Treatment Market Breakdown, by End Users
11. Competitive Landscape
11.1 Heat Map Analysis by Key Players
11.2 Company Positioning & Concentration
12. Global Colorectal Cancer Treatment Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies
12.2.1 Overview
13. Company Profiles
13.1 Amgen Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Genentech Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.3 Bayer AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.4 Eli Lilly and Co
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Pfizer Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Takeda Pharmaceutical Co Ltd
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Bristol-Myers Squibb Co
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Teva Pharmaceutical Industries Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.9 Regeneron Pharmaceuticals Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.10 Otsuka Holdings Co Ltd
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 List of Abbreviations
List of Tables
Table 1. Colorectal Cancer Treatment Market Segmentation
Table 2. Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million)
Table 3. Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million)
Table 4. Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Treatment
Table 5. Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Treatment
Table 6. Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Age Group
Table 7. Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group
Table 8. Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End Users
Table 9. Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End Users
Table 10. North America: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Treatment
Table 11. North America: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Treatment
Table 12. North America: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Age Group
Table 13. North America: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group
Table 14. North America: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End Users
Table 15. North America: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End Users
Table 16. North America: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 17. North America: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 18. United States: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Treatment
Table 19. United States: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Treatment
Table 20. United States: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Age Group
Table 21. United States: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group
Table 22. United States: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End Users
Table 23. United States: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End Users
Table 24. Canada: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Treatment
Table 25. Canada: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Treatment
Table 26. Canada: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Age Group
Table 27. Canada: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group
Table 28. Canada: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End Users
Table 29. Canada: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End Users
Table 30. Mexico: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Treatment
Table 31. Mexico: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Treatment
Table 32. Mexico: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Age Group
Table 33. Mexico: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group
Table 34. Mexico: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End Users
Table 35. Mexico: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End Users
Table 36. Europe: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Treatment
Table 37. Europe: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Treatment
Table 38. Europe: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Age Group
Table 39. Europe: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group
Table 40. Europe: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End Users
Table 41. Europe: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End Users
Table 42. Europe: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 43. Europe: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 44. Germany: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Treatment
Table 45. Germany: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Treatment
Table 46. Germany: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Age Group
Table 47. Germany: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group
Table 48. Germany: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End Users
Table 49. Germany: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End Users
Table 50. France: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Treatment
Table 51. France: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Treatment
Table 52. France: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Age Group
Table 53. France: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group
Table 54. France: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End Users
Table 55. France: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End Users
Table 56. United Kingdom: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Treatment
Table 57. United Kingdom: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Treatment
Table 58. United Kingdom: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Age Group
Table 59. United Kingdom: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group
Table 60. United Kingdom: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End Users
Table 61. United Kingdom: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End Users
Table 62. Italy: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Treatment
Table 63. Italy: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Treatment
Table 64. Italy: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Age Group
Table 65. Italy: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group
Table 66. Italy: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End Users
Table 67. Italy: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End Users
Table 68. Spain: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Treatment
Table 69. Spain: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Treatment
Table 70. Spain: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Age Group
Table 71. Spain: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group
Table 72. Spain: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End Users
Table 73. Spain: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End Users
Table 74. Rest of Europe: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Treatment
Table 75. Rest of Europe: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Treatment
Table 76. Rest of Europe: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Age Group
Table 77. Rest of Europe: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group
Table 78. Rest of Europe: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End Users
Table 79. Rest of Europe: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End Users
Table 80. Asia Pacific: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Treatment
Table 81. Asia Pacific: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Treatment
Table 82. Asia Pacific: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Age Group
Table 83. Asia Pacific: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group
Table 84. Asia Pacific: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End Users
Table 85. Asia Pacific: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End Users
Table 86. Asia Pacific: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 87. Asia Pacific: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 88. China: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Treatment
Table 89. China: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Treatment
Table 90. China: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Age Group
Table 91. China: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group
Table 92. China: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End Users
Table 93. China: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End Users
Table 94. Japan: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Treatment
Table 95. Japan: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Treatment
Table 96. Japan: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Age Group
Table 97. Japan: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group
Table 98. Japan: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End Users
Table 99. Japan: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End Users
Table 100. India: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Treatment
Table 101. India: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Treatment
Table 102. India: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Age Group
Table 103. India: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group
Table 104. India: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End Users
Table 105. India: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End Users
Table 106. South Korea: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Treatment
Table 107. South Korea: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Treatment
Table 108. South Korea: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Age Group
Table 109. South Korea: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group
Table 110. South Korea: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End Users
Table 111. South Korea: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End Users
Table 112. Australia: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Treatment
Table 113. Australia: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Treatment
Table 114. Australia: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Age Group
Table 115. Australia: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group
Table 116. Australia: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End Users
Table 117. Australia: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End Users
Table 118. Rest of APAC: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Treatment
Table 119. Rest of APAC: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Treatment
Table 120. Rest of APAC: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Age Group
Table 121. Rest of APAC: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group
Table 122. Rest of APAC: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End Users
Table 123. Rest of APAC: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End Users
Table 124. Middle East and Africa: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Treatment
Table 125. Middle East and Africa: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Treatment
Table 126. Middle East and Africa: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Age Group
Table 127. Middle East and Africa: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group
Table 128. Middle East and Africa: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End Users
Table 129. Middle East and Africa: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End Users
Table 130. Middle East and Africa: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 131. Middle East and Africa: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 132. Saudi Arabia: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Treatment
Table 133. Saudi Arabia: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Treatment
Table 134. Saudi Arabia: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Age Group
Table 135. Saudi Arabia: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group
Table 136. Saudi Arabia: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End Users
Table 137. Saudi Arabia: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End Users
Table 138. South Africa: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Treatment
Table 139. South Africa: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Treatment
Table 140. South Africa: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Age Group
Table 141. South Africa: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group
Table 142. South Africa: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End Users
Table 143. South Africa: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End Users
Table 144. United Arab Emirates: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Treatment
Table 145. United Arab Emirates: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Treatment
Table 146. United Arab Emirates: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Age Group
Table 147. United Arab Emirates: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group
Table 148. United Arab Emirates: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End Users
Table 149. United Arab Emirates: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End Users
Table 150. Rest of Middle East and Africa: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Treatment
Table 151. Rest of Middle East and Africa: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Treatment
Table 152. Rest of Middle East and Africa: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Age Group
Table 153. Rest of Middle East and Africa: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group
Table 154. Rest of Middle East and Africa: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End Users
Table 155. Rest of Middle East and Africa: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End Users
Table 156. South and Central America: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Treatment
Table 157. South and Central America: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Treatment
Table 158. South and Central America: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Age Group
Table 159. South and Central America: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group
Table 160. South and Central America: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End Users
Table 161. South and Central America: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End Users
Table 162. South and Central America: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 163. South and Central America: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 164. Brazil: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Treatment
Table 165. Brazil: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Treatment
Table 166. Brazil: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Age Group
Table 167. Brazil: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group
Table 168. Brazil: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End Users
Table 169. Brazil: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End Users
Table 170. Argentina: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Treatment
Table 171. Argentina: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Treatment
Table 172. Argentina: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Age Group
Table 173. Argentina: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group
Table 174. Argentina: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End Users
Table 175. Argentina: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End Users
Table 176. Rest of South and Central America: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Treatment
Table 177. Rest of South and Central America: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Treatment
Table 178. Rest of South and Central America: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Age Group
Table 179. Rest of South and Central America: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group
Table 180. Rest of South and Central America: Colorectal Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End Users
Table 181. Rest of South and Central America: Colorectal Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End Users
Table 182. Heat Map Analysis by Key Players
Table 183. Recent Growth Strategies in the Global Colorectal Cancer Treatment Market
Table 184. List of Abbreviations
List of Figures
Figure 1. Colorectal Cancer Treatment Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Colorectal Cancer Treatment Market Revenue (US$ Million), 2021–2031
Figure 5. Colorectal Cancer Treatment Market Share (%) – by Treatment (2024 and 2031)
Figure 6. Surgery: Colorectal Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Chemotherapy: Colorectal Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Immunotherapy: Colorectal Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Targeted Therapy: Colorectal Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Others: Colorectal Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Colorectal Cancer Treatment Market Share (%) – by Age Group (2024 and 2031)
Figure 12. Below 49 Years: Colorectal Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. - 64 Years: Colorectal Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Above 65 Years: Colorectal Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Colorectal Cancer Treatment Market Share (%) – by End Users (2024 and 2031)
Figure 16. Hospitals: Colorectal Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Specialty Clinics: Colorectal Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Home Care: Colorectal Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Others: Colorectal Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Colorectal Cancer Treatment Market Breakdown by Region, 2024 and 2031 (%)
Figure 21. North America: Colorectal Cancer Treatment Market – Revenue, 2021–2031 (US$ Million)
Figure 22. North America: Colorectal Cancer Treatment Market Breakdown, by Treatment (2024 and 2031)
Figure 23. North America: Colorectal Cancer Treatment Market Breakdown, by Age Group (2024 and 2031)
Figure 24. North America: Colorectal Cancer Treatment Market Breakdown, by End Users (2024 and 2031)
Figure 25. North America: Colorectal Cancer Treatment Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 26. United States: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 27. Canada: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 28. Mexico: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 29. Europe: Colorectal Cancer Treatment Market – Revenue, 2021–2031 (US$ Million)
Figure 30. Europe: Colorectal Cancer Treatment Market Breakdown, by Treatment (2024 and 2031)
Figure 31. Europe: Colorectal Cancer Treatment Market Breakdown, by Age Group (2024 and 2031)
Figure 32. Europe: Colorectal Cancer Treatment Market Breakdown, by End Users (2024 and 2031)
Figure 33. Europe: Colorectal Cancer Treatment Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 34. Germany: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 35. France: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 36. United Kingdom: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 37. Italy: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 38. Spain: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 39. Rest of Europe: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 40. Asia Pacific: Colorectal Cancer Treatment Market – Revenue, 2021–2031 (US$ Million)
Figure 41. Asia Pacific: Colorectal Cancer Treatment Market Breakdown, by Treatment (2024 and 2031)
Figure 42. Asia Pacific: Colorectal Cancer Treatment Market Breakdown, by Age Group (2024 and 2031)
Figure 43. Asia Pacific: Colorectal Cancer Treatment Market Breakdown, by End Users (2024 and 2031)
Figure 44. Asia Pacific: Colorectal Cancer Treatment Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 45. China: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 46. Japan: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 47. India: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 48. South Korea: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 49. Australia: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 50. Rest of APAC: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 51. Middle East and Africa: Colorectal Cancer Treatment Market – Revenue, 2021–2031 (US$ Million)
Figure 52. Middle East and Africa: Colorectal Cancer Treatment Market Breakdown, by Treatment (2024 and 2031)
Figure 53. Middle East and Africa: Colorectal Cancer Treatment Market Breakdown, by Age Group (2024 and 2031)
Figure 54. Middle East and Africa: Colorectal Cancer Treatment Market Breakdown, by End Users (2024 and 2031)
Figure 55. Middle East and Africa: Colorectal Cancer Treatment Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 56. Saudi Arabia: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 57. South Africa: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 58. United Arab Emirates: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 59. Rest of Middle East and Africa: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 60. South and Central America: Colorectal Cancer Treatment Market – Revenue, 2021–2031 (US$ Million)
Figure 61. South and Central America: Colorectal Cancer Treatment Market Breakdown, by Treatment (2024 and 2031)
Figure 62. South and Central America: Colorectal Cancer Treatment Market Breakdown, by Age Group (2024 and 2031)
Figure 63. South and Central America: Colorectal Cancer Treatment Market Breakdown, by End Users (2024 and 2031)
Figure 64. South and Central America: Colorectal Cancer Treatment Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 65. Brazil: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 66. Argentina: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 67. Rest of South and Central America: Colorectal Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 68. Company Positioning & Concentration
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For